Showing results (151-160 of 170) with videos related to
Sort By:
Pageof 17
Prostate Cancer and Prostatic Diseases|September 3, 2008
Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillanceS Jhavar, J Bartlett, G Kovacs, et al.British Journal of Cancer|August 27, 2009
Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangementC S Foster, A R Dodson, L Ambroisine, et al.Journal of Medicinal Chemistry|October 9, 1999
Synthesis and antimicrobial activity of 4H-4-oxoquinolizine derivatives: consequences of structural modification at the C-8 positionZ Ma, D T Chu, C S Cooper, et al.Oncogene|October 18, 2006
Diversity of TMPRSS2-ERG fusion transcripts in the human prostateJ Clark, S Merson, S Jhavar, et al.Oncogene|October 9, 2007
Complex patterns of ETS gene alteration arise during cancer development in the human prostateJ Clark, G Attard, S Jhavar, et al.British Journal of Cancer|May 23, 2013
Prognostic value of PTEN loss in men with conservatively managed localised prostate cancerJ Cuzick, Z H Yang, G Fisher, et al.British Journal of Cancer|February 20, 2003
Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profilingY-F Lee, M John, S Edwards, et al.British Journal of Cancer|February 1, 2014
Focal amplification of the androgen receptor gene in hormone-naive human prostate cancerS Merson, Z H Yang, D Brewer, et al.British Journal of Cancer|November 13, 2008
TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancerJ F Knight, C J Shepherd, S Rizzo, et al.Oncogene|July 20, 2007
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancerG Attard, J Clark, L Ambroisine, et al.Pageof 17